106 related articles for article (PubMed ID: 8125839)
1. Cefuroxime concentrations in serum, joint fluid and bone in elderly patients undergoing arthroplasty after administration of cefuroxime axetil.
Renneberg J; Christensen OM; Thomsen NO; Tørholm C
J Antimicrob Chemother; 1993 Nov; 32(5):751-5. PubMed ID: 8125839
[No Abstract] [Full Text] [Related]
2. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
3. Determination of serum and bone concentrations of cephradine and cefuroxime by HPLC in patients undergoing hip and knee joint replacement surgery.
Leigh DA
J Antimicrob Chemother; 1989 Jun; 23(6):877-83. PubMed ID: 2759931
[TBL] [Abstract][Full Text] [Related]
4. [Cefuroxime axetil (Zinnat)--laboratory and clinical study].
Vyhnánek F; Hejzlar M; Procházka M; Pellar T; St'astná L; Silarová J; Kittnar E; Vedral T
Rozhl Chir; 1990 Oct; 69(10):668-73. PubMed ID: 2263996
[TBL] [Abstract][Full Text] [Related]
5. Cefuroxime axetil in the sick elderly patient.
Cowling P; Case CP; MacGowan AP; Lovering AM; Humphreys H; Reeves DS; Madan I; Harding M; Harvey JE
J Antimicrob Chemother; 1992 Mar; 29(3):350-1. PubMed ID: 1592706
[No Abstract] [Full Text] [Related]
6. Bronchoalveolar distribution of cefuroxime axetil and in-vitro efficacy of observed concentrations against respiratory pathogens.
Baldwin DR; Andrews JM; Wise R; Honeybourne D
J Antimicrob Chemother; 1992 Sep; 30(3):377-85. PubMed ID: 1452503
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
[TBL] [Abstract][Full Text] [Related]
9. [Serum, knee synovial fluid and joint tissue cefuroxime concentration in perioperative use before orthopedic interventions after tourniquet or in the bloodless field].
Rütt J; Althoff F
Z Orthop Ihre Grenzgeb; 1992; 130(2):104-8. PubMed ID: 1598765
[TBL] [Abstract][Full Text] [Related]
10. Model simulation of a single oral dose of cefuroxime axetil and the related in-vitro kill kinetics against four bacterial species.
Silley P; Monsey D; Harris AM
J Antimicrob Chemother; 1990 Jan; 25(1):83-90. PubMed ID: 2180892
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
[TBL] [Abstract][Full Text] [Related]
12. Plasma and bone concentrations of cefuroxime and flucloxacillin. Oral versus parenteral administration in 20 arthroplasties.
Alvarez Ferrero MM; Vree TB; Baars AM; Slooff TJ
Acta Orthop Scand; 1993 Oct; 64(5):525-9. PubMed ID: 8237317
[TBL] [Abstract][Full Text] [Related]
13. Bone levels of cephradine and cefuroxime after intravenous administration in patients undergoing total hip replacement.
Cain TJ; Jones GT; Woods P
Int Orthop; 1987; 11(1):61-3. PubMed ID: 3557757
[TBL] [Abstract][Full Text] [Related]
14. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
15. Comparative investigations on the bioavailability of cefuroxime axetil.
Kees F; Lukassek U; Naber KG; Grobecker H
Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
[TBL] [Abstract][Full Text] [Related]
16. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment.
Brink HS; Huisman RM; Geerlings W; de Jong PE
Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy and tolerability of cefuroxime-axetil in infections of the upper respiratory tract. Comparative study with cefadroxil].
Dupuis G; Ebbo D; Evennou A; Pappo M
Rev Laryngol Otol Rhinol (Bord); 1989; 110(1):123-6. PubMed ID: 2491707
[TBL] [Abstract][Full Text] [Related]
18. Stereoselective absorption and hydrolysis of cefuroxime axetil diastereomers using the Caco-2 cell monolayer model.
Barrett MA; Lawrence MJ; Hutt AJ; Lansley AB
Eur J Drug Metab Pharmacokinet; 1997; 22(4):409-13. PubMed ID: 9512942
[TBL] [Abstract][Full Text] [Related]
19. Comparison of oral cefuroxime axetil and oral amoxycillin/clavulanate in the treatment of community-acquired pneumonia.
Higuera F; Hidalgo H; Feris J; Giguere G; Collins JJ
J Antimicrob Chemother; 1996 Mar; 37(3):555-64. PubMed ID: 9182112
[TBL] [Abstract][Full Text] [Related]
20. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
